维普中文期刊产品整合服务
848篇 您的检索式:作者名="NAIR N"
    题名 作者 年代 出处 被引量
1重组脊髓灰质炎病毒用于治疗复发胶质母细胞瘤(英文)显示文摘Background The prognosis of patients with recurrent World Health Organization(WHO)grade IV malignant glioma is dismal,and there is currently no effective therapy.We conducted a dose-finding and toxicity study in this population of patients,evaluating convection-enhanced,intratumoral delivery of the recombinant nonpathogenic polio-rhinovirus chimera(PVSRIPO).PVSRIPO recognizes the poliovirus receptor CD155,which is widely expressed in neoplastic cells of solid tumors and in major components of the tumor microenvironment.Methods We enrolled consecutive adult patients who had recurrent supratentorial WHO grade IV malignant glioma,confirmed on histopathological testing,with measurable disease(contrast-enhancing tumor of≥1 cm and≤5.5 cm in the greatest dimension).The study evaluated seven doses,ranging between 107 and 1010 50%tissue-culture infectious doses(TCID50),first in a dose-escalation phase and then in a dose-expansion phase.Results From May 2012 through May 2017,a total of 61 patients were enrolled and received a dose of PVSRIPO.Dose level-1(5.0×107TCID50)was identified as the phase 2 dose.One dose-limiting toxic effect was observed;a patient in whom dose level 5(1010TCID50)was administered had a grade 4 intracranial hemorrhage immediately after the catheter was removed.To mitigate locoregional inflammation of the infused tumor with prolonged glucocorticoid use,dose level 5 was deescalated to reach the phase 2 dose.In the dose-expansion phase,19%of the patients had a PVSRIPO-related adverse event of grade 3 or higher.Overall survival among the patients who received PVSRIPO reached a plateau of 21%(95%confidence interval,11 to 33)at 24 months that was sustained at 36 months.Conclusions Intratumoral infusion of PVSRIPO in patients with recurrent WHO grade IV malignant glioma confirmed the absence of neurovirulent potential.The survival rate among patients who receivedPVSRIPO immunotherapy was higher at 24 and 36 months than the rate among historical controls.Desjardins A Gromeier M Herndon JE 2nd Beaubier N Bolognesi DP Friedman AH Friedman HS McSherry F Muscat AM Nair S Peters KB Randazzo D Sampson JH Vlahovic G Harrison WT McLendon RE Ashley D Bigner DD 2018中华神经外科疾病研究杂志2018,17,4:2
2Analysis of Alloys by Prompt Gamma-ray Neutron Activation显示文摘Nair AGC Sudarshan K Raje N 2004Nuclear Instruments and Methods in Physics Research A2004,516,1:1
3Biocompatibility of b-tricalcium phosphate root replicas in porcine tooth extraction sockets-A correlative histological,ultrastructural,and Xray microanalytical pilot study显示文摘Nair P N R Luder H U Maspero F A 2006J Biomater Appl2006,20,:1
4Adsorption and Photocatalytic Oxidation of Acetone on TiO2 :An in Situ Transmission FT-IR Study显示文摘El-Maazawi M Finken A N Nair A B 2000Catal2000,191,:1
5Fine Structure Constant Defines Visual Transparency of Graphene显示文摘Nair R R Blake P Grigorenko A N 2008Science2008,320,5881:1
6Determination of optical parameters of human breast tissue from spatially resolved fluorescence: a diffusion theory model 显示文摘Nair M Ghosh N Raju N 2002Appl Opt2002,41,19:1
7Production of artemisinin in tissue cultures of Artemisia annua显示文摘Nair M S R Acton N Klayman D C 1986J Nat Prod1986,49,3:1
8Investigations on the cure chemistry and polymer properties of benzoxazine - eyanate ester blends显示文摘Santhosh Kumar K S Reghunadhan Nair C P Ninan K N 2009European Polymer Journal2009,45,2:1
9In-plane and transverse rubber composites显示文摘Das J N Nair N G Subramaniam N 1993Rubber and Composites:Processing and Applications1993,22,:1
10Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana 显示文摘JAYAPRAKASAM B SEERAM N P NAIR M G 2003Cancer Letters2003,189,1:1
11Fine structure constant defines visual transparency of graphene显示文摘Nair R R Blake P Grigorenko A N 2008Science2008,320,5881:1
12L - arginine supplementation in peripheral arterial disease: no benefit and possible harm 显示文摘Wilson AM Harada R Nair N 2007Circulation2007,116,2:1
13Pemetrexed/gemcitabine as front-line therapy for advanced NSCLC:A randomized,phase Ⅱtrial of three schedules显示文摘Adjei AA Nair S Reuter N 2004Proc Am Soc Clin Oncol2004,23,:1
14Pathophysiologyandmanagementofneurocar-diogenicsyncope显示文摘Nair N Padder FA Kantharia BK 2003Am J Manag Care2003,9,4:1
15Fuzzy Models for Single-period Inventory Problem 显示文摘Li L Kabadi S N Nair K P K 2002Fuzzy sets and systems2002,,132:1
16Phosphazene Triazine Cyclomatrix Network Polymers:Some Aspects of Synthesis, Thermal- and Flame-retardant Characteristics显示文摘Mathew D Nair C P R Ninan K N 2000Polym Int2000,49,1:1
17Serum proealcitonin and infective exacerbations of asthma显示文摘Dsilva L Hassan N Nair P 2011Chest2011,140,5:1
18An overview of the recent developments in polyl_actide ( PEA ) research 显示文摘Madhavan Nampoothiri K Nair N R John R P 2010Bioresource Technol2010,101,22:1
19Characterization of polystyrene filled with HgS nanoparticles显示文摘P Sreekumari Nair T Radhakrishnan N Revaprasadu 2004Materials Letter2004,58,34:1
20Permutation Entropy Based Real-Time Chatter Detection Using Audio Signal in Turning Process显示文摘Nair U Krishna B M Namboothiri V N N 0,,01:1
返回顶部 每页显示:
共43页 首页 上一页 第1页 下一页 末页 /43 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费